for people ages 2 years and up (full criteria)
at Sacramento, California and other locations
study started
estimated completion



TARGET-NASH is a longitudinal observational cohort study of patients being managed for NAFL or NASH in usual clinical practice. TARGET-NASH will create a research registry of patients with NAFL or NASH within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.


Nonalcoholic Fatty Liver Nonalcoholic Steatohepatitis Fatty Liver Non-alcoholic Fatty Liver Disease


You can join if…

Open to people ages 2 years and up

  1. Adults and children (age 2 or older) being managed or treated for nonalcoholic fatty liver disease. Diagnosis is based on the clinical judgement of the care provider.

You CAN'T join if...

  1. Inability to provide written informed assent/consent
  2. Simultaneous enrollment in another registry, study, or clinical trial where NASH treatment outcomes are reported, except where approved or conducted as an adjunct project of TARGET-NASH. If a participant elects to enroll in an interventional clinical trial during their enrollment in TARGET-NASH, records submissions for the participant will be put 'on hold' for the trial duration. When participation in the trial is complete, records submissions for TARGET-NASH will resume.


  • University of California, Davis accepting new patients
    Sacramento California 95817 United States
  • Stanford University accepting new patients
    Palo Alto California 94304 United States


accepting new patients
Start Date
Completion Date
Target PharmaSolutions, Inc.
Sign up for this study
Study Type
Observational [Patient Registry]
Last Updated